Verrica Pharmaceuticals Inc. (VRCA) Net margin 2021–2025
Verrica Pharmaceuticals Inc. (VRCA) net profit margin by fiscal year — reported net income divided by reported revenue.
-50.3%FY2025 · since FY2021: -292.3% → -50.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -50.3% | +961.9 pp |
| FY2024 | -1012.1% | +295.3 pp |
| FY2023 | -1307.5% | -1036.4 pp |
| FY2022 | -271.1% | +21.2 pp |
| FY2021 | -292.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More VRCA financial trends
VRCA RevenueVRCA Net incomeVRCA Gross profitVRCA Gross marginVRCA Operating incomeVRCA Operating marginVRCA Operating cash flowVRCA Free cash flowVRCA Capital expendituresVRCA Return on equityVRCA Stock buybacksVRCA Dividends paidVRCA Total assetsVRCA Total liabilitiesVRCA Shareholders’ equityVRCA overview →